Breast Cancer Takeaways from ASCO

episode

Cleveland Clinic Cancer Advances not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

A.I. Safety Goes Mainstream + a ‘Hard Fork’ Exit AMA 1h 25m · 18 Sep 2026 · Hard Fork

Layoffs at the Kansas City Star will hurt local communities 15 min · 18 Sep 2026 · Kansas City Today

AWP: Beyond the Exam Room: Purpose, Myopia, and Population Health 54 min · 17 Sep 2026 · EyeCode Media

Planning Commission Meeting - Sep 17, 2026 1h 11m · 17 Sep 2026 · Leesburg Planning Commission

Heritage Commission - Sep 14, 2026 1h 57m · 17 Sep 2026 · Loudoun County Board Committees and Advisory Boards

Historic District Review Committee - Sep 14, 2026 1h 36m · 17 Sep 2026 · Loudoun County Board Committees and Advisory Boards

Report any issue

Source

Recorded24 Jul 2025

Publisherfeeds.buzzsprout.com

Handlerec:1648130

Show notes

Megan Kruse, MD, a Medical Oncologist and Director of the Clinical Breast Cancer Research Program at Cleveland Clinic joins the Cancer Advances Podcast to share breast cancer research highlights from the 2025 ASCO Conference. She discusses key findings from studies in metastatic hormone receptor-positive, triple-negative, and HER2-positive breast cancer, including potential practice-changing data on oral SERDs, antibody-drug conjugates, and ctDNA testing.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in